Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scientists Create First Mouse Model of Typhoid Fever

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
Columbia University Medical Center (CUMC) researchers have created the first true mouse model of typhoid infection.

The development promises to advance the study of typhoid and the creation of new vaccines against the infection, which remains a major health threat in developing countries. The paper was published today in the online edition of the journal Cell.

“Vaccines are the most practical solution for preventing typhoid in the Third World. Unfortunately, existing typhoid vaccines are only modestly effective, leaving millions of people vulnerable to infection. With our new mouse model, the first of its kind, we have a powerful tool for investigating the disease and devising better vaccine strategies,” said study co-leader Sankar Ghosh, PhD, the Silverstein and Hutt Family Professor and chair of microbiology & immunology at CUMC.

Typhoid is caused by the bacterium Salmonella typhi, which is spread through contaminated drinking water or food. While typhoid is rare in the United States, it is a common health problem in the developing world, affecting more than 2 million people each year and leading to 200,000 deaths. Symptoms of typhoid infection include high fever, fatigue, stomach pains, headache, and loss of appetite. Typhoid can be treated with antibiotics. Without therapy, the illness may last up to a month, with a fatality rate between 12 and 30 percent. There are two typhoid vaccines, with efficacy rates ranging from 50 to 80 percent.

Since mice and other laboratory animals are resistant to S. typhi, it has been difficult to develop and test new vaccination approaches. In the current experiment, Dr. Ghosh and his colleagues sought to determine why mice cannot be infected with S. typhi, with the ultimate goal of creating an animal model for studying the disease.

Evidence suggested that toll-like receptors (TLRs), which are expressed on the surface of key immune cells such as macrophages and dendritic cells, might be involved. Such cells are part of the innate immune response, the body’s first-line defense against infectious microbes. For various reasons, the researchers zeroed in on a particular TLR: TLR11. One, this receptor is expressed all over the gastrointestinal lining, or epithelium, where S. typhi infection begins, and two, the receptor is found in mice, but not in humans. Also, in an earlier study, the CUMC team found that TLR11 protects mice infected with the Toxoplasma gondii, the parasite that causes toxoplasmosis in humans.

To determine whether TLR11 protects mice against S. typhi, Dr. Ghosh created a strain of mice that lack the receptor. When the TLR11 “knockout” mice were challenged with orally administered S. typhi, they developed typhoid-like symptoms. Next, the researchers demonstrated that the mice could be successfully immunized against S. typhi with a heat-killed vaccine.

The researchers also showed that this protection could be transferred by passive transfer — that is, by taking serum from a vaccinated mouse and giving it to a non-vaccinated mouse. “This is important for two reasons,” said study co-leader Matthew S. Hayden, MD, PhD, assistant professor of dermatology and of microbiology & immunology at CUMC. “First, it demonstrated that these mice are capable of a robust response that includes protective antibodies. Second, passive immunization can be used to identify the protective component of the immune response and the parts of the bacteria that vaccination should target.”

Other research teams have created small-animal models of typhoid, but all have serious drawbacks. The main drawback is that these models are chimeras, with a mix of mouse and human cells. While these models can be infected with S. typhi, only the human cells are actually infected. Thus, the models do not reflect the animals’ true immune response. In addition, these models cannot be infected orally, only by systemic injection. “Normally S. typhi must breach the intestinal barrier and then disseminate within innate immune cells, including intestinal macrophages. Injecting the bacteria systemically bypasses these essential steps in the infection cycle. These are the steps that vaccination should block, however, because bacteria are injected in these other models, efficacy at these steps cannot be tested,” said Dr. Hayden.

The CUMC team also discovered that TLR11 protects mice against S. typhi by recognizing and binding to flagellin, a protein found in the bacterium’s flagellum, the whip-like tail that it uses to propel itself. The researchers are currently exploring whether TLR11 contributes to the failure of other flagellated bacteria to infect mice. “We are particularly excited that the TLR11 knockout may be an animal model for other enteropathogens” — pathogens that cause intestinal disease — “and potentially, other flagellated epithelial pathogens, including those that infect the lungs and urogenital tract. At present, there are no good mouse models for enterohemorrhagic E. coli, Vibrio cholera, Clostridium difficile, or chronic Pseudomonas aeruginosa,” said Dr. Hayden.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Detecting Alzheimer's with a Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Thursday, July 28, 2016
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Tuesday, June 28, 2016
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Tuesday, June 28, 2016
New Neurodevelopmental Syndrome Identified
Study pinpoints underlying genetic mutations, raising hopes for targeted therapies.
Friday, April 22, 2016
Major Complication of Parkinson’s Therapy Explained
Researchers have discovered why long-term use of ¬¬¬L-DOPA (levodopa), the most effective treatment for Parkinson’s disease, commonly leads to a movement problem called dyskinesia, a side effect that can be as debilitating as Parkinson’s disease itself.
Monday, September 14, 2015
An Innovative Algorithm to Decipher How Drugs Work Inside the Body
Researchers at Columbia University Medical Center (CUMC) have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body.
Friday, July 24, 2015
Neurons Controlling Appetite Made from Skin Cells
Cells provide individualized model for studying obesity and testing treatments.
Monday, March 02, 2015
Bone Stem Cells Shown To Regenerate Bone And Cartilage In Adult Mice
Cells could be exploited to treat osteoarthritis and osteoporosis.
Monday, January 19, 2015
Non-Gluten Proteins as Targets of Immune Response to Wheat in Celiac Disease
The results were reported online in the Journal of Proteome Research.
Thursday, December 18, 2014
Human Stem Cells Converted to Functional Lung Cells
Possibility of generating lung tissue for transplant using a patient’s own cells.
Thursday, December 05, 2013
New Link Between Obesity and Diabetes Found
Targeting a single enzyme that raises both sugar and insulin levels in the obese could prevent and treat diabetes.
Monday, November 25, 2013
Human Stem Cells Elucidate Mechanisms of Beta-Cell Failure in Diabetes
Mechanisms that impair insulin production in diabetes identified using a human stem cell model of Wolfram syndrome, a rare form of diabetes.
Thursday, November 14, 2013
Researchers Discover Cells that Restore Bladder’s Unique Lining
Finding that could lead to new ways to treat chronic bladder pain or to produce new tissue for patients with damaged bladders.
Tuesday, September 24, 2013
Trial Aims to Advance Prenatal Diagnosis of Genetic Defects
High-risk pregnant women being recruited for research on chromosomal abnormalities and incidence of birth defects, developmental delays.
Thursday, August 22, 2013
Is There a Role for Vitamins in Cancer Prevention?
According to recent national surveys, approximately 40 percent of U.S. adults take multivitamins/multiminerals.
Monday, August 12, 2013
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
“Sixth Sense” May Be More Than Just A Feeling
The NIH Study shows that two young patients with a mutation in the PIEZ02 have problems with touch and proprioception, or body awareness.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Plant Pathogens with RNA
Researchers develop strategy that could lead to environmentally friendly fungicide to fight pathogens.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!